Carmine De Angelis
Baylor College of Medicine(US)Scuola Superiore Meridionale(IT)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Estrogen and related hormone effects, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Treatment landscape of triple-negative breast cancer — expanded options, evolving needs(2021)1,247 cited
- → ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer(2015)659 cited
- → Towards personalized treatment for early stage HER2-positive breast cancer(2019)291 cited
- → Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up(2012)262 cited
- → FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer(2016)183 cited
- → FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer(2019)165 cited
- → HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade(2019)164 cited
- → Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance(2020)132 cited
- → Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer(2018)131 cited
- → The changing role of ER in endocrine resistance(2015)129 cited